$2.270
+0.149 (+6.57%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Jupiter Neurosciences Inc (JUNS) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting JUNS is Strong sell.
Jupiter Neurosciences Inc (JUNS) 20-Day simple moving average is 2.67, while Jupiter Neurosciences Inc (JUNS) share price is $—, making it Sell.
Jupiter Neurosciences Inc (JUNS) 60-Day simple moving average is 3.25, while Jupiter Neurosciences Inc (JUNS) share price is $—, making it Sell.
Technical Analysis for JUNS
AI Technical JUNSAs of 2026-11-07, the technical board for Jupiter Neurosciences Inc (JUNS) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $2.27 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 38.81, MACD stands at -0.258 (Sell), Stochastic %K stands at 18.875 (Buy), Stochastic %D stands at 23.71 and CCI stands at -117.715 (Buy).
JUNS trades below the 60-day SMA (3.25) and below the 200-day SMA (18.93). Immediate resistance sits at Classic R1 2.93, then R2 3.47. Support sits at Classic S1 1.93, then S2 1.47.
Jupiter Neurosciences Inc (JUNS) Support & Resistance Level
Jupiter Neurosciences Inc (JUNS) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 38.810 |
| STOCHk_14_3_3 | 18.875 |
| STOCHd_14_3_3 | 23.710 |
| CCI_20 | -117.715 |
| AO_5_34 | -0.426 |
| MOM_10 | -0.780 |
| MACD_12_26_9 | -0.258 |
Jupiter Neurosciences Inc (JUNS) Relative Strength Index (RSI_14) is 38.810, creating a Neutral signal.
Jupiter Neurosciences Inc (JUNS) Stochastic %K is 18.875, creating a Buy signal.
Jupiter Neurosciences Inc (JUNS) Stochastic %D is 23.710, creating a Neutral signal.
Jupiter Neurosciences Inc (JUNS) CCI_20 is -117.715, creating a Buy signal.
Jupiter Neurosciences Inc (JUNS) Awesome Oscillator (AO) is -0.426, creating a Sell signal.
Jupiter Neurosciences Inc (JUNS) Momentum (MOM) is -0.780, creating a Sell signal.
Jupiter Neurosciences Inc (JUNS) Moving Average Convergence Divergence (MACD) is -0.258, creating a Sell signal.
Jupiter Neurosciences Inc (JUNS) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.306 | Sell |
| MA_10 | 2.395 | Sell |
| MA_20 | 2.674 | Sell |
| MA_60 | 3.253 | Sell |
| MA_200 | 18.931 | Sell |
| MA_250 | 31.973 | Sell |
Jupiter Neurosciences Inc (JUNS) 5-Day simple moving average is 2.306, while Jupiter Neurosciences Inc (JUNS) share price is $, making it a Sell.
Jupiter Neurosciences Inc (JUNS) 10-Day simple moving average is 2.395, while Jupiter Neurosciences Inc (JUNS) share price is $, making it a Sell.
Jupiter Neurosciences Inc (JUNS) 20-Day simple moving average is 2.674, while Jupiter Neurosciences Inc (JUNS) share price is $, making it a Sell.
Jupiter Neurosciences Inc (JUNS) 60-Day simple moving average is 3.253, while Jupiter Neurosciences Inc (JUNS) share price is $, making it a Sell.
Jupiter Neurosciences Inc (JUNS) 200-Day simple moving average is 18.931, while Jupiter Neurosciences Inc (JUNS) share price is $, making it a Sell.
Jupiter Neurosciences Inc (JUNS) 250-Day simple moving average is 31.973, while Jupiter Neurosciences Inc (JUNS) share price is $, making it a Sell.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.